Explore the Global Complex Generics Market — analysis of key trends, regional growth, top players, and a 10-year forecast from 2026 to 2036.

Future Market Insights

Complex Generics Market

Key Insight

Injectable nano-suspension will lead complex generics sales through 2036 with 63.0% of the form segment in 2026. The market was valued at USD 90.68 billion in 2025 and is expected to be worth USD 213.60 billion by 2036, creating an incremental opportunity of USD 115.57 billion between 2026 and 2036.

May 21, 2026

Anurag Sharma

250 Pages

Cite this Report

Complex Generics Market

https://www.futuremarketinsights.com/reports/complex-generics-market

License

Buy Now

Summary ToC Infographics Companies

Key Players

Amneal Pharmaceuticals LLC
Cipla Ltd
Hikma Pharmaceuticals PLC
Lupin
Sun Pharmaceuticals Ltd
Teva Pharmaceuticals
Viatris Inc

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Complex Generics Market

Key Players

Similar Industry Reports